[go: up one dir, main page]

NO941151D0 - Linear adhesion inhibitors - Google Patents

Linear adhesion inhibitors

Info

Publication number
NO941151D0
NO941151D0 NO941151A NO941151A NO941151D0 NO 941151 D0 NO941151 D0 NO 941151D0 NO 941151 A NO941151 A NO 941151A NO 941151 A NO941151 A NO 941151A NO 941151 D0 NO941151 D0 NO 941151D0
Authority
NO
Norway
Prior art keywords
adhesion inhibitors
linear adhesion
linear
inhibitors
adhesion
Prior art date
Application number
NO941151A
Other languages
Norwegian (no)
Other versions
NO941151L (en
Inventor
Alfred Jonczyk
Beate Diefenbach
Brunhilde Felding-Habermann
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO941151D0 publication Critical patent/NO941151D0/en
Publication of NO941151L publication Critical patent/NO941151L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO941151A 1993-04-01 1994-03-29 Linear adhesion inhibitors NO941151L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4310632A DE4310632A1 (en) 1993-04-01 1993-04-01 Linear Adhesion Inhibitors

Publications (2)

Publication Number Publication Date
NO941151D0 true NO941151D0 (en) 1994-03-29
NO941151L NO941151L (en) 1994-10-03

Family

ID=6484423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941151A NO941151L (en) 1993-04-01 1994-03-29 Linear adhesion inhibitors

Country Status (10)

Country Link
EP (1) EP0618225A1 (en)
JP (1) JPH06321988A (en)
CN (1) CN1099040A (en)
AU (1) AU5798494A (en)
CA (1) CA2120302A1 (en)
CZ (1) CZ70394A3 (en)
DE (1) DE4310632A1 (en)
HU (1) HU9400932D0 (en)
NO (1) NO941151L (en)
SK (1) SK38494A3 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US5874562A (en) * 1995-06-07 1999-02-23 Progenitor, Inc. Nucleic acid encoding developmentally-regulated endothelial cell locus-1
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
JPH11510814A (en) * 1995-08-30 1999-09-21 ジー．ディー．サール アンド カンパニー Meta-guanidine, urea, thiourea or azacyclic aminobenzoic acid derivatives as integrin antagonists
ES2247621T3 (en) 1996-02-15 2006-03-01 Biosense Webster, Inc. EXCAVATION PROBE.
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
US6309370B1 (en) 1998-02-05 2001-10-30 Biosense, Inc. Intracardiac drug delivery
PL350291A1 (en) 1998-12-23 2002-12-02 Searle & Co Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
PL363153A1 (en) 2000-06-16 2004-11-15 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
GB0323378D0 (en) 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
PT1737889E (en) 2004-10-19 2010-12-13 Lonza Ag Method for solid phase peptide synthesis
EP2187916A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of gluten exorphin c as a therapeutic agent
US20100190717A1 (en) * 2007-09-11 2010-07-29 Dorian Bevec Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
CN106279362B (en) * 2015-06-23 2019-07-12 首都医科大学 Arg-Leu-Val-Cys-Val, synthesis, pharmacological activity and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049659A (en) * 1988-02-09 1991-09-17 Dana Farber Cancer Institute Proteins which induce immunological effector cell activation and chemattraction
US5196511A (en) * 1989-12-01 1993-03-23 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding

Also Published As

Publication number Publication date
AU5798494A (en) 1994-10-06
CN1099040A (en) 1995-02-22
EP0618225A1 (en) 1994-10-05
SK38494A3 (en) 1995-02-08
CA2120302A1 (en) 1994-10-02
CZ70394A3 (en) 1994-12-15
JPH06321988A (en) 1994-11-22
DE4310632A1 (en) 1994-10-06
NO941151L (en) 1994-10-03
HU9400932D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
NO942064D0 (en) inhibitors
FI962315A0 (en) Enzyme inhibitors
FI963597L (en) Isoprenyltransferase inhibitors
NO972930D0 (en) Fibronectin-adhesion inhibitors
FI972160A0 (en) Matriisimetalloproteaasi inhibitors
ATE189461T1 (en) CYCLIC ADHESION INHIBITORS
DE59409721D1 (en) Wording
FI933303L (en) ADENOSINCINE INHIBITORS
DK0526251T3 (en) Corrosion inhibitors
DE69410747D1 (en) coating
FI961044L (en) Kininogen inhibitors
NO941151D0 (en) Linear adhesion inhibitors
FI932094A0 (en) KYLNINGSAPPARAT I KRANENS VAEXEL
NO923339D0 (en) corrosion inhibitors
FI932264A0 (en) Gapformare i en pappersmaskin
DE69431454D1 (en) Amylase inhibitors
BR9610514A (en) Cycloantihelmintic inhibitors
DK31493A (en) Mile Facing
FI930927A0 (en) BANFORMNINGSPARTI I EN PAPPERSMASKIN
BR9302518A (en) Adhesive
CY2007006I2 (en) ALIPOPROTEIN-B INHIBITORS
KR950013554U (en) Carpenter
KR950010788U (en) Capricorn
KR950016508U (en) Capricorn
BR9300120A (en) Polychronic coating